Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
1.460
+0.110 (8.15%)
At close: Mar 13, 2026, 4:00 PM EDT
1.473
+0.013 (0.90%)
After-hours: Mar 13, 2026, 7:58 PM EDT
Treace Medical Concepts Revenue
In the year 2025, Treace Medical Concepts had annual revenue of $212.69M with 1.59% growth. Treace Medical Concepts had revenue of $62.52M in the quarter ending December 31, 2025, a decrease of -9.01%.
Revenue (ttm)
$212.69M
Revenue Growth
+1.59%
P/S Ratio
0.44
Revenue / Employee
$472,644
Employees
450
Market Cap
94.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 212.69M | 3.33M | 1.59% |
| Dec 31, 2024 | 209.36M | 22.24M | 11.89% |
| Dec 31, 2023 | 187.12M | 45.28M | 31.92% |
| Dec 31, 2022 | 141.84M | 47.42M | 50.22% |
| Dec 31, 2021 | 94.42M | 37.05M | 64.59% |
| Dec 31, 2020 | 57.37M | 17.95M | 45.54% |
| Dec 31, 2019 | 39.42M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xtant Medical Holdings | 133.08M |
| Neuronetics | 129.87M |
| Pulmonx | 90.50M |
| LENSAR | 59.14M |
| MaxCyte | 34.42M |
| Baird Medical Investment Holdings | 31.86M |
| QT Imaging Holdings | 18.93M |
| Hyperfine | 10.59M |
TMCI News
- 15 days ago - Treace Medical Concepts, Inc. (TMCI) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results - GlobeNewsWire
- 18 days ago - Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference - GlobeNewsWire
- 23 days ago - First Eagle Small Cap Opportunity Fund Q4 2025 Portfolio Review - Seeking Alpha
- 4 weeks ago - Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026 - GlobeNewsWire
- 2 months ago - Treace Medical Concepts, Inc. (TMCI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue - GlobeNewsWire
- 2 months ago - Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology - GlobeNewsWire